X @Bloomberg
Funding & Acquisition - Novo Nordisk is expected to raise approximately €35 billion (350 亿欧元) through a multi-tranche euro bond sale [1] - The funding is intended for Novo Nordisk's planned acquisition of US biotech Akero Therapeutics [1]